Mariia G. Glezer

Mariia G. Glezer

Auto-generated profile, based on publicly available information

Mariia G. Glezer

Moscow Regional Research and Clinical Institute (MONIKI)

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
ZKZh. D. Kobalava
Zh. D. Kobalava
AKA. O. Konradi
A. O. Konradi
SNS. V. Nedogoda
S. V. Nedogoda
GAG. P. Arutyunov
G. P. Arutyunov
EBElena Baranova
Elena Baranova
GCGalina Chumakova
Galina Chumakova
Меморандум экспертов Российского кардиологического общества по рекомендациям Европейского общества кардиологов/Европейского общества по артериальной гипертензии по лечению артериальной гипертензии 2018г

1 February 2010 in Emergency Medicine Journal
Verified
Journal Article
Closed access
PDF file
RSRuslan T Saygitov
Ruslan T Saygitov
MGMarya G Glezer
Marya G Glezer
SSSvetlana V Semakina
Svetlana V Semakina
Purpose To compare the prognostic significance of blood urea nitrogen (BUN) versus creatinine levels for estimating the risk of death in patients with acute coronary syndrome (ACS). Methods and results A prospective study of all patients admitted with suspected (n=1613) and retrospectively confirmed (n=54) myocardial infarction or unstable angina was conducted. The ROC analysis established that the area under the curve for BUN was higher than that of creatinine: 0.76 (95% CI 0.70 to 0.82) and 0.69 (95% CI 0.63 to 0.76), respectively (p=0.005). The threshold level (that maximised the combined sensitivity and specificity) was 8.8 mmol/l for BUN and 110 μmol/l for creatinine. Sensitivity (true positive cases) was 60% and 55% for threshold levels of BUN and creatinine, respectively, and specificity (true negative cases) was 82% and 77%, respectively. An increase of only BUN levels and a combination of increased BUN and creatinine levels, but not isolated hypercreatinaemia, proved to be the independent risk factors of death from ACS. Separate inclusion of BUN and creatinine as continuous variables in the regression model showed that both were associated with the risk of death: OR 1.22 (95% CI 1.17 to 1.28) and 1.016 (95% CI 1.011 to 1.021) per unit increase (R2=14.5 and 8.4%, respectively). When both were simultaneously included, only an increased BUN level was pertinent to the prognosis of ACS: OR after multivariate adjustment 1.17 (95% CI 1.08 to 1.27). Conclusion An increased level of BUN is a more significant risk factor for ACS outcomes than that of creatinine.

11 June 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
MBMarina G. Bubnova
Marina G. Bubnova
ESE. V. Shlyakhto
E. V. Shlyakhto
DAD. M. Aronov
D. M. Aronov
ABA. S. Belevsky
A. S. Belevsky
MGM. Yu. Gerasimenko
M. Yu. Gerasimenko
VTV. A. Tutelian
V. A. Tutelian
The expert consensus of the Russian communities discusses the issues of comprehensive medical rehabilitation of patients with coronavirus disease 2019 (COVID-19). COVID-19 is a contagious infectious disease that can cause pulmonary, cardiac, motor, metabolic, neurocognitive and mental disorders, that is, multiple organ dysfunction. COVID-19 survivors, especially after a severe clinical course, face serious psychological and physical problems, posttraumatic stress, cognitive dysfunction, nutritional deficiencies and exacerbation of concomitant chronic diseases. Some patients, regardless of the COVID-19 severity, have a long clinical course of the disease (“chronic-COVID”, “long COVID”). There is evidence of post-acute COVID-19 syndrome. In this regard, patients after COVID-19 will need rehabilitation measures. The expert consensus of the Russian communities presents general principles, stages and aspects of medical rehabilitation after COVID-19, indications and contraindications for rehabilitation interventions. The paper includes recommendations on comprehensive cardiac and pulmonary rehabilitation, as well as specifics of rehabilitation care for different COVID-19 courses within the national three-stage rehabilitation system.

19 July 2001 in Neurological Research
Verified
Journal Article
Closed access
JRJames Reggia
James Reggia
SGSharon M. Goodall
Sharon M. Goodall
YSYuri Shkuro
Yuri Shkuro
MGMark Glezer
Mark Glezer
It is often suggested that a major factor in diaschisis is the loss of transcallosal excitation to the intact hemisphere from the lesioned one. However, there is long-standing disagreement in the broader experimental literature about whether transcallosal interhemispheric influences in the human brain are primarily excitatory or inhibitory. Some experimental data are apparently better explained by assuming inhibitory callosal influences. Past neural network models attempting to explore this issue have encountered the same dilemma: in intact models, inhibitory callosal influences best explain strong cerebral lateralization like that occurring with language, but in lesioned models, excitatory callosal influences best explain experimentally observed hemispheric activation patterns following brain damage. We have now developed a single neural network model that can account for both types of data, i.e., both diaschisis and strong hemisphere specialization in the normal brain, by combining excitatory callosal influences with subcortical cross-midline inhibitory interactions. The results suggest that subcortical competitive processes may be a more important factor in cerebral specialization than is generally recognized.

31 May 2000 in Brain and Language
Verified
Journal Article
Closed access
YSYuri Shkuro
Yuri Shkuro
MGMark Glezer
Mark Glezer
JRJames A. Reggia
James A. Reggia

10 October 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ESE. V. Shlyakhto
E. V. Shlyakhto
YBYuri Belenkov
Yuri Belenkov
SBSergey Boytsov
Sergey Boytsov
SVSvetlana Villevalde
Svetlana Villevalde
AGAlbert Galyavich
Albert Galyavich
EZE. A. Zorina
E. A. Zorina
Aim. Geographic heterogeneity of phenotypes and prognosis in heart failure (HF) highlights the need for region-specific data. The aim of the study was to evaluate characteristics, therapy, and 1-year outcomes in a Russian large representative cohort of outpatients with HF.Material and methods. PRIORITY-HF is a prospective, observational, multicenter registry study. From 2020 to 2022, outpatients diagnosed with HF aged 18 years and older were included in 50 regions of the Russian Federation.Results. The study included 19,981 patients with HF (mean age 64.9 years; 63.5% men). HF with reduced ejection fraction (HFrEF) was diagnosed in 34.9% of patients, while HF with mildly reduced ejection fraction (HFmrEF) — in 24.7%, and HF with preserved ejection fraction (HFpEF) — in 40.4%. The most common comorbidities were hypertension (89.0%), coronary artery disease (73.4%), obesity (45.2%), chronic kidney disease (44.7%), and atrial fibrillation/flutter (42.5%).There was high prescription rate of individual classes of recommended HF therapy as follows: 92% of patients received renin-angiotensin-aldosterone system inhibitors, 86% — beta-blockers, 72% — mineralocorticoid receptor antagonists and 40% — sodium-glucose cotransporter-2 inhibitors, but only 46.6% of patients with HFrEF received quadruple therapy.After 12 months, all-cause mortality was 5.2% in the overall group (HFrEF: 8.1%; HFmrEF: 4.6%; HFpEF: 3.1%), while cumulative HF-related hospitalization rate — 6.3% (HFrEF: 10.4%; HFmrEF: 6.2%; HFpEF: 2.9%).Conclusion. The obtained data indicate a relatively young age of patients with HF in Russia with a high level of comorbidities and suboptimal therapy, especially in HFrEF. With relatively low mortality and rehospitalization rates, significant differences between the EF subgroups were revealed, which emphasizes the need for targeted interventions to improve the quality of care and prognosis.